Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
AEHA Stock Summary
In the News
AEHA Financial details
Company Rating
Neutral
Market Cap
364.37M
Income
-1.09B
Revenue
0
Book val./share
-0
Cash/share
0
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
-228.52
Forward P/E
-
PEG
-2.61
P/S
-
P/B
160134.27
P/C
-
P/FCF
-0.49
Quick Ratio
0.01
Current Ratio
0.01
Debt / Equity
-1.41
LT Debt / Equity
-
-
-
EPS (TTM)
-0.42
EPS next Y
-
EPS next Q
-
EPS this Y
766.51%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-90%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0%
Inst Trans
0%
ROA
-4332%
ROE
-4%
ROC
-666.06%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
3.79-14.22
52W High
-
52W Low
-
RSI
-
Rel Volume
7.15
Avg Volume
180.5K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
-
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
AEHA Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2021-12-31 | 2022-12-31 |
---|---|---|---|
2.02K | 2.02K | ||
Revenue per share | 0 | 0 | |
Net income per share | -0.04 | -0.37 | |
Operating cash flow per share | -0.06 | -0.28 | |
Free cash flow per share | -0.06 | -0.28 | |
Cash per share | 0.08 | 42.2 | |
Book value per share | 7.96 | 39.73 | |
Tangible book value per share | 7.96 | 39.73 | |
Share holders equity per share | 7.96 | 39.73 | |
Interest debt per share | 0 | 0.82 | |
Market cap | 132.12M | 27.3B | |
Enterprise value | 131.04M | 29.12B | |
P/E ratio | -234.21 | -28.48 | |
Price to sales ratio | 0 | 0 | |
POCF ratio | -166.31 | -36.53 | |
PFCF ratio | -166.31 | -36.53 | |
P/B Ratio | 1.26 | 0.26 | |
PTB ratio | 1.26 | 0.26 | |
EV to sales | 0 | 0 | |
Enterprise value over EBITDA | -232.3 | -30.36 | |
EV to operating cash flow | -164.96 | -38.97 | |
EV to free cash flow | -164.96 | -38.97 | |
Earnings yield | 0 | -0.04 | |
Free cash flow yield | -0.01 | -0.03 | |
Debt to equity | 0 | 0.02 | |
Debt to assets | 0 | 0.02 | |
Net debt to EBITDA | 1.91 | -1.9 | |
Current ratio | 6.29 | 0.14 | |
Interest coverage | 0 | 1.39K | |
Income quality | 1.41 | 0.78 | |
Dividend Yield | 0 | 0 | |
Payout ratio | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | |
Research and developement to revenue | 0 | 0 | |
Intangibles to total assets | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | |
Capex to revenue | 0 | 0 | |
Capex to depreciation | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | |
Graham number | 2.76 | 18.07 | |
ROIC | -0.01 | -0.01 | |
Return on tangible assets | -0.01 | -0.01 | |
Graham Net | -0.18 | 39.68 | |
Working capital | 1.3M | -3B | |
Tangible asset value | 105.26M | 104.3B | |
Net current asset value | -1.85M | -6.15B | |
Invested capital | 0 | 0.02 | |
Average receivables | 0 | 0 | |
Average payables | 0 | 162.43M | |
Average inventory | 0 | 0 | |
Days sales outstanding | 0 | 0 | |
Days payables outstanding | 0 | 23.89 | |
Days of inventory on hand | 0 | 0 | |
Receivables turnover | 0 | 0 | |
Payables turnover | 0 | 15.28 | |
Inventory turnover | 0 | 0 | |
ROE | -0.01 | -0.01 | |
Capex per share | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | -0.05 | -0.36 | 0 | 0 | |
Operating cash flow per share | -0.01 | -0.02 | -0.28 | 0 | 0 | |
Free cash flow per share | -0.01 | -0.02 | -0.28 | 0 | 0 | |
Cash per share | 8.15 | 8.24 | 42.2 | 0 | 0 | |
Book value per share | 7.93 | 7.86 | 39.73 | 0 | 0 | |
Tangible book value per share | 7.93 | 7.86 | 39.73 | 0 | 0 | |
Share holders equity per share | 7.93 | 7.86 | 39.73 | 0 | 0 | |
Interest debt per share | -0.01 | 0.05 | 0.82 | 0 | 0 | |
Market cap | 133.7M | 134.76M | 27.3B | 247.25B | 263.66B | |
Enterprise value | 133.13M | 135.34M | 29.12B | 247.25B | 263.67B | |
P/E ratio | -748.84 | -50.58 | -7.13 | -499.72 | -5.06K | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | -1.37K | -429.47 | -36.56 | -93.27K | -20.24K | |
PFCF ratio | -1.37K | -429.47 | -36.56 | -93.27K | -20.24K | |
P/B Ratio | 1.27 | 1.3 | 0.26 | 160.13K | -31.38K | |
PTB ratio | 1.27 | 1.3 | 0.26 | 160.13K | -31.38K | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | -409.33 | -98.82 | -30.39 | -19.54K | -20.24K | |
EV to operating cash flow | -1.37K | -431.31 | -39 | -93.27K | -20.24K | |
EV to free cash flow | -1.37K | -431.31 | -39 | -93.27K | -20.24K | |
Earnings yield | 0 | 0 | -0.04 | 0 | 0 | |
Free cash flow yield | 0 | 0 | -0.03 | 0 | 0 | |
Debt to equity | 0 | 0.01 | 0.02 | 4.58 | -1.41 | |
Debt to assets | 0 | 0.01 | 0.02 | 0.28 | 0.57 | |
Net debt to EBITDA | 1.77 | -0.42 | -1.9 | -0.53 | -0.82 | |
Current ratio | 1.47 | 0.29 | 0.14 | 0.01 | 0.08 | |
Interest coverage | 2.32 | 3.89 | 1.39K | 44.68 | 19.5 | |
Income quality | 0.53 | 0.31 | 0.78 | 0.04 | 1 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.78 | 2.98 | 18.06 | 0 | 0 | |
ROIC | 0 | -0.01 | -0.01 | -14.69 | -3.75 | |
Return on tangible assets | 0 | -0.01 | -0.01 | -4.95 | -0.62 | |
Graham Net | 7.88 | 7.85 | 39.68 | 0 | 0 | |
Working capital | 239.19K | -1.49M | -3B | -23.13M | -24.52M | |
Tangible asset value | 104.91M | 103.89M | 104.3B | 1.54M | -8.4M | |
Net current asset value | -2.91M | -4.64M | -6.15B | -23.13M | -27.16M | |
Invested capital | 0 | 0.01 | 0.02 | 4.58 | -1.41 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 105.24K | 163.04K | 162.51M | 162.41M | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 20.07 | 5.95 | 5.89 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 4.48 | 15.13 | 15.28 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | -0.01 | -0.01 | -80.11 | 1.55 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
AEHA Frequently Asked Questions
What is Aesther Healthcare Acquisition Corp. stock symbol ?
Aesther Healthcare Acquisition Corp. is a US stock , located in New york of Ny and trading under the symbol AEHA
What is Aesther Healthcare Acquisition Corp. stock quote today ?
Aesther Healthcare Acquisition Corp. stock price is $- today.
Is Aesther Healthcare Acquisition Corp. stock public?
Yes, Aesther Healthcare Acquisition Corp. is a publicly traded company.